Skip to main content

Ernexa Therapeutics Inc.

ERNAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000748592

No open-market purchases or sales by Ernexa Therapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $202.3K in total; no superinvestor holds it.

Other share classesERNA

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ernexa Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ernexa Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ernexa Therapeutics Inc.
NameTitleLast reported holdingLast filingFilings, past year
Bristol James ArthurDirector–Sep 1, 20261
Cicala PeterDirector–Sep 1, 20261
Polinsky DavidDirector–Sep 1, 20261
Wexler William A.Director–Sep 1, 20261
Ratner ElenaDirector–Sep 1, 20261
Luther SanjeevPresident and CEO–Sep 1, 20261
Cherington Charles10% Owner6,779,440Feb 17, 20261
Gurrola Sandra MSr. VP of Finance110Jul 7, 20250
Clarke Dorothy JGeneral Counsel–Jan 3, 20240
Huff Curtis W10% Owner–Dec 18, 20230
Freebird Partners LP10% Owner–Dec 18, 20230
Freebird Investments LLC10% Owner–Dec 18, 20230
Binder BrantOther: Former director–Aug 10, 20230
Wagner Richard WOther: Former director–Aug 10, 20230
Angel MatthewPresident and CEO–Jan 13, 20230
Singer Nicholas JasonDirector266,214IndirectDec 6, 20220
Halpern John D10% Owner450,961IndirectDec 5, 20220
Sidhu RogerChief Medical Officer20,163Sep 21, 20220
Fiore GregoryDirector–Aug 3, 20220
DAmour KevinChief Scientific Officer11,496Jun 29, 20220
Jackson Andrew C.Chief Financial Officer–Jun 6, 20220
Federoff Howard J.CEO & President–Mar 17, 20220
Sial JayChief Administration Officer–Mar 17, 20220
Enright Erin S.Director–Jan 19, 20220
Redman Heather BDirector–Jan 19, 20220
Langer DennisDirector–Dec 10, 20210
Mohr ErichDirector–Dec 10, 20210
Greenwood LubaDirector–Dec 10, 20210
Denny George P III10% Owner3IndirectAug 20, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 17, 2026 (view filing)Feb 107 daysLateCherington Charles10% OwnerPPurchase+4.00M$0.50+$2.00M+143.9%6.78M after
Feb 17, 2026 (view filing)Feb 107 daysLateCherington Charles10% OwnerPPurchase+4.00M–––4.00M afterDerivative
Jun 11, 2025 (view filing)8:34 PM ETJun 92 daysCherington Charles10% OwnerPPurchase+21.2M$0.1046+$2.22M+104.0%41.7M after
May 7, 2025 (view filing)11:48 AM ETSep 24, 2024225 daysCherington Charles10% OwnerPPurchase+13.3M––+2,381.5%13.8M afterAmended5 lots
May 7, 2025 (view filing)11:48 AM ETSep 24, 2024225 daysCherington Charles10% OwnerSSale−10.5M–––0 afterAmendedDerivative5 lots
Apr 4, 2025 (view filing)10:54 AM ETApr 22 daysCherington Charles10% OwnerPPurchase+3.77M$0.1046+$394.2K+22.7%20.4M after
Nov 5, 2024 (view filing)12:42 PM ETSep 23-2443 daysCherington Charles10% OwnerPPurchase+2.99M–––AmendedDerivative5 lotsPrice outlier
Dec 20, 2023 (view filing)10:05 AM ETDec 146 daysLateCherington Charles10% OwnerPPurchase+7.52M$0.0833+$390.7K–523.5K afterDerivative4 lotsPrice outlier
Dec 18, 2023 (view filing)9:38 PM ETDec 153 daysHuff Curtis W and 2 others10% OwnerPPurchaseCommon Stock, par value $0.005 per share+1.56M$1.92+$1.00M–1.99M afterDerivative2 lots
Aug 25, 2023 (view filing)7:34 PM ETJul 1343 daysLateCherington Charles10% OwnerPPurchase+3.46M$0.0833+$288.5K–2.31M afterDerivative2 lotsPrice outlier
Jul 18, 2023 (view filing)4:15 PM ETJul 135 daysLateBinder BrantDirectorPPurchase+125.9K$0.0833+$10.5K–83.9K afterDerivative2 lotsPrice outlier
Jul 18, 2023 (view filing)4:15 PM ETJul 135 daysLateWagner Richard WDirectorPPurchase+125.9K$0.0833+$10.5K–83.9K afterDerivative2 lotsPrice outlier
Jul 18, 2023 (view filing)6:10 AM ETJul 144 daysHuff Curtis W and 2 others10% OwnerPPurchaseCommon Stock, par value $0.005 per share+786.7K$2.86+$750.0K–949.4K afterDerivative2 lots
Dec 6, 2022 (view filing)9:02 PM ETDec 24 daysCherington CharlesDirector, 10% OwnerPPurchase+261.8K$3.28+$858.6K+88.8%556.5K after
Dec 6, 2022 (view filing)9:02 PM ETDec 24 daysCherington CharlesDirector, 10% OwnerPPurchaseCommon Stock, par value $0.005 per share+523.5K$0.125+$65.4K–523.5K afterDerivative
Dec 6, 2022 (view filing)6:52 PM ETDec 24 daysSinger Nicholas JasonDirectorPPurchase+283.3K$3.28+$929.2KNew position266.2K after2 lots
Dec 6, 2022 (view filing)6:52 PM ETDec 24 daysSinger Nicholas JasonDirectorPPurchaseCommon Stock, par value $0.005 per share+566.6K$0.125+$70.8K–424.9K afterDerivative2 lots
Dec 5, 2022 (view filing)6:05 PM ETDec 23 daysHalpern John D10% OwnerPPurchase+335.9K$3.28+$1.10M+292.0%451.0K after
Dec 5, 2022 (view filing)6:05 PM ETDec 23 daysHalpern John D10% OwnerPPurchase+671.8K$0.125+$84.0K–671.8K afterDerivative
Aug 20, 2021 (view filing)Jul 645 daysLateDenny George P III10% OwnerSSale−75.0K$16.06−$1.20M−1.5%4.78M after
Aug 20, 2021 (view filing)Jul 8-1443 daysLateDenny George P III10% OwnerPPurchase+3$13.48+$40.45New position3 after3 lots